BMJ 1997;315:510-514 (30 August)

Papers

Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study

Oliver Blatchford, audit research fellow,a Lindsay A Davidson, director of audit,a William R Murray, consultant surgeon,b Mary Blatchford, general practitioner,c Jill Pell, senior registrar in public health medicine d

a Royal College of Physicians and Surgeons of Glasgow, Glasgow G2 5RJ, b Glasgow Royal Infirmary NHS Trust, Glasgow G31 2ER, c Easterhouse Health Centre, Glasgow G34 9HQ, d Department of Public Health, Greater Glasgow Health Board, Glasgow G1 1ET

Correspondence to: Dr O Blatchford Department of Public Health, University of Glasgow, Glasgow G12 8RZ o.blatchford@udcf.gla.uk

Objectives: To determine the incidence and case fatality of acute upper gastrointestinal haemorrhage in the west of Scotland and to identify associated factors.
Design: Case ascertainment study.
Setting: All hospitals treating adults with acute upper gastrointestinal haemorrhage in the west of Scotland.
Subjects: 1882 patients aged 15 years and over treated in hospitals for acute upper gastrointestinal haemorrhage during a six month period.
Main outcome measures: Incidence of acute upper gastrointestinal haemorrhage per 100 000 population per year, and case fatality.
Results: The annual incidence was 172 per 100 000 people aged 15 and over. The annual population mortality was 14.0 per 100 000. Both were higher among elderly people, men, and patients resident in areas of greater social deprivation. Overall case fatality was 8.2%. This was higher among those who bled as inpatients after admission for other reasons (42%) and those admitted as tertiary referrals (16%). Factors associated with increased case fatality were age, uraemia, pre-existing malignancy, hepatic failure, hypotension, cardiac failure, and frank haematemesis or a history of syncope at presentation. Social deprivation, sex, and anaemia were not associated with increased case fatality after adjustment for other factors.
Conclusions: The incidence of acute upper gastrointestinal haemorrhage was 67% greater than the highest previously reported incidence in the United Kingdom, which may be partially attributable to the greater social deprivation in the west of Scotland and may be related to the increased prevalence of Helicobacter pylori. Fatality after acute upper gastrointestinal haemorrhage was associated with age, comorbidity, hypotension, and raised blood urea concentrations on admission. Although deprivation was associated with increased incidence, it was not related to the risk of fatality.

Key messages

  • The incidence of upper gastrointestinal haemorrhage in the west of Scotland was 67% higher than the highest incidence previously reported in the United Kingdom

  • A substantial part of this excess incidence may be attributable to socioeconomic deprivation

  • The overall population mortality from upper gastrointestinal haemorrhage may increase as the elderly population increases because both incidence and case fatality rise steeply with age

  • A reduction in the overall case fatality from acute upper gastrointestinal haemorrhage will be best achieved by reducing case fatality among elderly patients


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
Julia Hippisley-Cox, Carol Coupland, and Richard Logan
BMJ 2005 331: 1310-1316. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Robins, G G, Sarwar, M S, Armstrong, M, Denyer, M E, Bush, S, Hassan, T, Everett, S M (2007). Evaluation of the need for endoscopy to identify low-risk patients presenting with an acute upper gastrointestinal bleed suitable for early discharge. Postgrad. Med. J. 83: 768-772 [Abstract] [Full text]  
  • Sung, J. J Y, Tsoi, K. K F, Lai, L. H, Wu, J. C Y, Lau, J. Y W (2007). Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis. Gut 56: 1364-1373 [Abstract] [Full text]  
  • Williams, J G, Roberts, S E, Ali, M F, Cheung, W Y, Cohen, D R, Demery, G, Edwards, A, Greer, M, Hellier, M D, Hutchings, H A, Ip, B, Longo, M F, Russell, I T, Snooks, H A, Williams, J C (2007). Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence. Gut 56: 1-113 [Full text]  
  • Hippisley-Cox, J., Coupland, C., Logan, R. (2005). Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 331: 1310-1316 [Abstract] [Full text]  
  • (2004). Proton pump inhibitors for acute upper GI bleeding. DTB 42: 41-43 [Abstract] [Full text]  
  • Courtney, A E, Mitchell, R M S, Rocke, L, Johnston, B T (2004). Proposed risk stratification in upper gastrointestinal haemorrhage: Is hospitalisation essential?. Emerg. Med. J. 21: 39-40 [Abstract] [Full text]  
  • Barkun, A., Bardou, M., Marshall, J. K., for the Nonvariceal Upper GI Bleeding Consensus Co, (2003). Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding. ANN INTERN MED 139: 843-857 [Abstract] [Full text]  
  • van Walraven, C, Mamdani, M M, Wells, P S, Williams, J I (2001). Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 323: 655-655 [Abstract] [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ